Product Safety Manager
in health
The person who owns whether a health or life-sciences product is safe enough to ship and keeps proving it after launch.
A Product Safety Manager is the person accountable for whether a product is safe to use in real clinical and patient contexts, across its design, build, release, and ongoing operation. The product might be a medical device, a diagnostic assay, a medicine, or a piece of health software used inside an NHS trust. The job is the same shape in each setting: own the safety outcome, not just the safety paperwork, including the hard calls about what can ship, what must change, and what needs extra controls before it reaches patients or clinicians.
This role exists because health and life-sciences products change decisions and actions in the real world: triage, prescribing, monitoring, prioritisation, and access to care. When a product affects these pathways, usability and growth are not enough on their own. It also has to behave safely under expected use, misuse, edge cases, and failure modes. A Product Safety Manager gives the organisation clear accountability so safety does not become everyone's concern in theory and no one's responsibility in practice.
Where they sit varies by setting. In a device maker they often live close to Quality and Regulatory and answer to ISO 13485 and ISO 14971. In pharma they sit inside pharmacovigilance and the MHRA's Good Pharmacovigilance Practice. In a digital health scale-up selling into the NHS they carry the DCB0129 duty as a manufacturer and work alongside customer Clinical Safety Officers running DCB0160. In every version they sit near Product and Engineering but stay independent enough to challenge delivery pressure, and they work routinely with clinical leadership, quality, regulatory, security, and data protection.
How this role differs across settings
In many consumer or B2B software categories, the worst case of a poor release is churn, reputational damage, or financial loss. In health and life sciences, poor product behaviour can also create patient harm, clinician harm, or system harm: delays, incorrect prioritisation, unsafe recommendations, missed escalations, and workflow failures that only surface under pressure. That difference reshapes every decision. You often need to prove why a product is safe enough, not just show that it works.
The proof you have to assemble depends on the setting, and a good Product Safety Manager speaks the right language for each:
- In medical devices and diagnostics the spine is ISO 14971 risk management, an ISO 13485 quality system, MHRA oversight, and post-market surveillance that feeds vigilance reporting when something goes wrong in the field. Diagnostics add the demands of IVDR.
- In pharma the work is pharmacovigilance: signal detection, benefit-risk assessment, and safety reporting under MHRA GVP, where a missed signal can reach a very large patient population.
- In digital health and health IT the framework is DCB0129 for the manufacturer and DCB0160 for the deploying organisation, with a hazard log, a clinical safety case, and a named Clinical Safety Officer standing behind it.
Data sensitivity also changes the shape of risk. Safety decisions are frequently tangled up with privacy, security, identity, and access control, because the wrong user seeing the wrong information at the wrong time can become a safety event. Finally, safety here is rarely "one and done". Products evolve, clinical pathways change, integrations shift, and customers configure workflows differently. The Product Safety Manager is accountable for safety in a living system, not a static release.
Core responsibilities
On a typical day, a Product Safety Manager turns ambiguity into bounded risk decisions. They facilitate how the organisation identifies hazards, evaluates severity and likelihood, and agrees mitigations that teams can realistically build and customers can realistically adopt. They decide when risk is acceptable with controls, when it requires redesign, and when the safest decision is to pause.
- Run hazard identification and risk assessment across the product lifecycle, and keep the hazard log or risk file current as the product changes.
- Own the safety case or safety argument, so there is a defensible, evidenced reason the product is safe enough for its intended use.
- Set and hold release gates, deciding ship or do-not-ship and recording the rationale rather than rubber-stamping under deadline pressure.
- Align engineering, product, clinical, commercial, and customer teams when their goals pull in different directions, and make the trade-offs explicit.
- Lead post-market and post-go-live safety: triage incidents, investigate potential safety signals, and feed lessons back into the product.
- Meet the reporting and traceability duties of the setting, whether that is MHRA vigilance, GVP safety reporting, or a DCB0129 clinical safety case.
- Translate near misses into prevention rather than folklore, and build escalation paths that work when the system is under stress.
They spend real time aligning groups that naturally optimise for different outcomes: engineering for speed and reliability, product for value and adoption, clinical for appropriateness, commercial for timelines, and customer teams for deployability. Safety is where those trade-offs become explicit. The job is to make sure they are made consciously, recorded clearly, and revisited when assumptions change.
Skills and competencies
| Core skill | What it looks like in health and life sciences | Why it matters |
|---|---|---|
| Safety ownership | Willingness to be the named decision-maker when shipping creates clinical risk | Stops safety becoming a shared aspiration with no accountable owner when timelines tighten |
| Risk-based judgement | Reasoning about harm pathways under ISO 14971 or a clinical hazard log, not just software defects | Shifts focus from "bugs" to patient impact, including workflow and context-driven failure modes |
| Regulatory fluency | Knowing which framework governs the setting: ISO 13485, MHRA GVP, IVDR, or DCB0129 and DCB0160 | Lets you build the right evidence first time instead of reworking it under audit |
| Stakeholder authority | Confidence to challenge senior product and engineering decisions without becoming adversarial | Makes safety gates credible and prevents sign-off by default under delivery pressure |
| Clinical context literacy | Understanding how care is delivered, where cognitive load is high, and where handoffs fail | Helps predict real-world misuse and edge cases that never appear in test environments |
| Evidence and traceability | Comfort in environments that demand auditability, a clean hazard log, and a defensible rationale | Keeps safety decisions repeatable across releases, teams, and customers |
| Incident leadership | Running calm, structured reviews when a safety event or signal occurs | Reduces recurrence, sharpens learning loops, and builds trust with customers and regulators |
| Communication under constraint | Explaining nuanced risk decisions in plain language to non-specialists | Aligns teams and customers on what controls are required and why they matter |
| Systems thinking | Seeing that integrations, configurations, and operational processes change how a product behaves | Prevents designs that are safe in isolation but unsafe in deployed, configured reality |
Salary ranges in the UK
Pay for Product Safety Managers in UK health and life sciences is driven less by years in role and more by the scope of safety accountability and the setting. The biggest levers are: whether the product is patient-facing or clinician-facing, the criticality of the workflow, the level of authority to approve releases, the breadth of products owned, expectations for incident leadership, and whether the organisation needs formal assurance artefacts and safety sign-off. Setting matters too: drug-safety and pharmacovigilance leadership in pharma sits at the top of the range, while device, diagnostics, and digital health roles tend to sit lower for the same title. Location still counts, especially London and the South East, though high-accountability roles can compress the gap when hiring is competitive.
| Experience level | Estimated annual salary range | What drives compensation |
|---|---|---|
| Junior | London & South East: £38,000–£50,000 Rest of UK: £34,000–£45,000 | Supporting safety work under supervision, narrower product scope, limited sign-off authority, fewer customer-facing assurance responsibilities |
| Mid-level | London & South East: £50,000–£68,000 Rest of UK: £45,000–£62,000 | Owning safety activity for a product area, leading hazard reviews, influencing release readiness, growing responsibility for incident response and customer assurance |
| Senior | London & South East: £68,000–£90,000 Rest of UK: £62,000–£82,000 | Formal safety accountability across teams, stronger independence, complex integrations, higher-risk pathways, leading safety governance and escalation |
| Lead | London & South East: £90,000–£115,000 Rest of UK: £82,000–£105,000 | Owning the safety framework across a portfolio, setting standards and gates, mentoring other safety and clinical risk roles, carrying decision responsibility on ambiguous high-impact releases |
| Head / Director | London & South East: £115,000–£160,000 Rest of UK: £105,000–£145,000 | Organisation-wide accountability, board-level risk reporting, strategic ownership of safety posture, customer and partner assurance leadership, and responsibility for how safety scales with growth. The top of this band reflects pharma drug-safety leadership |
Sources: cross-referenced from Glassdoor UK (medical device safety officer and quality manager listings), a 2026 UK MedTech QA salary guide, Indeed UK and Hays pharmacovigilance figures, and the HSE Network UK safety manager report. Treat these as a guide; real offers move with employer, setting and specialism.
Beyond base salary, typical add-ons include a performance bonus (more common in venture-backed or scale-up digital health), employer pension contributions, and occasionally equity at mid-level and above. On-call allowances can appear where the role is tied to incident leadership for safety-critical workflows, but practice varies: some organisations rotate on-call across engineering while safety provides escalation, others expect safety leadership to be directly available for high-severity events. Total compensation tends to rise with the intensity of escalation expectations, the breadth of products covered, and the degree of independent release authority.
Career pathways
Many Product Safety Managers arrive from adjacent tracks: clinical safety and digital governance roles, quality and regulatory backgrounds, pharmacovigilance and drug safety, patient safety and risk functions, or engineering and product roles where they kept becoming the "risk person" during high-stakes releases. The most credible transitions come from demonstrated ownership: running incident reviews, shaping mitigation decisions, and building lightweight but reliable governance, rather than from collecting frameworks.
Over time, progression widens accountability. Early roles focus on supporting safety work and learning the domain. Mid-level roles take ownership of a product area and start making release and risk trade-offs with product and engineering. Senior and Lead roles expand into portfolio governance: standardising how hazards are handled, how evidence is maintained, how customers are assured, and how incidents become product improvements. Head and Director progression is defined by organisational capability: making safety scale across multiple teams, markets, and integrations without turning delivery into paralysis. Lateral moves into Regulatory Affairs, Quality, or Clinical Risk leadership are common, because the underlying judgement transfers across the sector.
FAQ
Do I need to be a clinician to become a Product Safety Manager? It depends on the setting. The DCB0160 Clinical Safety Officer duty for deploying health IT must be held by a suitably qualified and registered clinician, and some products or customer contexts require a clinically qualified safety signatory. Many device, diagnostics, and pharma safety roles, and the DCB0129 manufacturer side, are open to experienced safety, risk, quality, or engineering professionals who can show credible safety judgement. What matters most is your ability to reason about harm pathways and influence delivery decisions.
What will interviews actually test for? Expect scenario-based evaluation: ambiguous incidents, risky feature requests, and competing stakeholder priorities. You will likely be assessed on how you decide ship or do-not-ship, how you document rationale, and how you set mitigations that teams can realistically maintain. Strong candidates explain trade-offs calmly without defaulting to a blanket no, and can talk through the relevant framework, whether that is ISO 14971, GVP, or a DCB0129 safety case.
Is on-call part of the job? Sometimes, especially when the product supports time-critical pathways or the company has explicit safety escalation requirements. More often you will be part of an escalation chain rather than the primary on-call responder, with engineering owning the immediate technical response. Clarify the expectations early: rota frequency, what triggers escalation, and whether you are expected to make release or rollback decisions out of hours.
Find your next role
If you are ready to take ownership of safety outcomes across health and life sciences, search Product Safety Manager roles on Meeveem.